Diabetology & Metabolic Syndrome · Nov 19, 2026

Longitudinal associations between modified metabolic syndrome criteria and incident cardiovascular disease risk

By Xie Q, Xu S, Shen S et al.

Objective: To reduce cardiovascular disease (CVD) incidence, we developed and evaluated criteria for metabolic dysfunction syndrome (MDS) as an alternative framework to classical metabolic syndrome (cMS), assessed MDS components and combinations for CVD risk prediction in the UK Biobank (UKB) cohort, and evaluated these criteria across three independent Chinese cohorts. Methods: Cox regression, receiver operating characteristic (ROC) curves, and restricted cubic spline models were used to assess the associations between obesity indicators, MDS components, and CVD in the UKB cohort, adjusting for confounders. The diagnostic performance of MDS vs. cMS for CVD was compared via ROC analysis, with external evaluation performed in three independent Chinese cohorts: CHARLS served as the primary external evaluation cohort, and WCNPCS and Luzhou cohorts provided supportive external evaluation. Results: In the UKB cohort, isolated hypertension (iHT), isolated central adiposity (iCA), and several component combinations (DM + Pre-HT/MASLD, Pre-HT+LHDL-C/MASLD, high-risk MASLD+LHDL-C/HTG, and DM+LHDL-C + HTG) significantly increased CVD incidence (HR = 1.08–5.78; p < 0.05). Cox analysis revealed that both MDS and cMS increased subsequent CVD risk in the UKB cohort (HR = 1.35–1.82), with a directionally consistent trend across the Chinese cohorts. MDS showed a sensitivity of 84.2%–91.8%, higher than that of cMS, although at the cost of lower specificity, and was readily identifiable using simple, low-cost measurements. Isolated diabetes (iDM), a small subgroup with no other metabolic abnormalities, showed no significant CVD association in this subgroup. Conclusions: Based on 10-year UKB follow-up, the MDS criteria demonstrated higher sensitivity but lower specificity than cMS for identifying individuals at elevated CVD risk, and were supported by primary external validation in CHARLS and supportive external evaluation in the WCNPCS and Luzhou cohorts. These findings should be regarded as preliminary and hypothesis-generating; further independent, prospective validation is required before clinical implementation. Isolated hypertension and central adiposity emerged as the strongest single predictors, whereas isolated diabetes showed no significant association in its metabolically-uncomplicated subgroup and should not be generalized to diabetes overall.

doi.org/10.1186/s13098-026-02345-3Biomarkers

AgingResearch.News